Loading company…
Riskpilot
← Back to search
Sign in
Get full access
LIFE LAB PHARMA AS
AS
Active
Org 933332039
Bekkeveien 163, 3173 Vear
Retail sale of other food · NACE 4727
Est. 2024
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 7,9M
+520% vs 2024
EBITDA margin
5.6%
+163% vs 2024
Equity ratio
-11.4%
Financial strength
Net profit 2025
NOK 342K
+148% vs 2024
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
-1M
2024
0M
+100%
2025
Key figures
Annual report 2025
Revenue
NOK 7,9M
+520%
EBITDA
NOK 446K
+163%
Net profit
NOK 342K
+148%
Total assets
NOK 2,4M
+106%
Equity
NOK -270K
+56%
Employees
—
—
Company information
Legal name
LIFE LAB PHARMA AS
Org number
933332039
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
19. april 2024
Share capital
NOK 100 000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Utvikling og direktesalg av helsekost/kosttilskudd til forbruker og annet som naturlig tilhører herunder.
Contact
Address
Bekkeveien 163, 3173 Vear
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of other food
Companies in Tønsberg
All Norway companies
Revenue
NOK millions
0M
2M
5M
7M
9M
1M
2024
8M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
-1M
2024
0M
2025
Income statement
NOK thousands
Item
2024
2025
Revenue
1 281
7 945
Staff expenses
−158
−261
EBITDA
−710
446
Depreciation & amort.
−0
−0
EBIT
−710
446
Net financials
3
−103
Profit before tax
−707
342
Tax
−0
−0
Net profit
−707
342
Balance sheet
NOK thousands
Item
2024
2025
Total assets
1 152
2 378
Equity
−613
−270
Long-term debt
0
0
Short-term debt
1 764
2 601
Total debt
1 764
2 648
Financial ratios
5-year trend
EBITDA margin
5.6%
This company
15.8%
Market median
-65% vs market
2024
2025
Equity ratio
-11.4%
This company
38.2%
Market median
-130% vs market
2024
2025
Return on equity
34235200.0%
This company
18.4%
Market median
+186060770% vs market
2024
2025
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
2024
2025
Asset turnover
3.34×
This company
1.12×
Market median
+198% vs market
2024
2025
Debt / equity
9.79×
This company
0.62×
Market median
-1479% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-04-04 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
DT
Dag Tore Skjøthaug
Chief Executive Officer
Chief Executive Officer
2024
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
TA
Terje Andre Skulbru
Board of Directors
2024
—
—
DH
Daniel Helmut Podpeskar-Johansen
Chairman
2024
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of LIFE LAB PHARMA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Dag Tore Skjøthaug
Chief Executive Officer
0 companies
Terje Andre Skulbru
Board of Directors
0 companies
Daniel Helmut Podpeskar-Johansen
Chairman
0 companies